Advancing Discovery

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of drug discovery.

In-Person & Online Events

Collaborate & Partner for a Better Future

Explore Discovery

Unite with the drug discovery industry's foremost leaders and scientific experts through our year-round activities. Immerse yourself in cutting-edge scientific content that sparks thought-provoking insights, providing a unique perspective on the latest R&D trends and challenges.

Resources & Announcements

09/05/24 - Profluent successfully combined large language models (LLMs) and CRISPR for an open-source AI gene editing project which could reshape CRISPR treatment options.
09/04/24 - Two case studies show how digital therapeutics can potentially treat neurological and neuropsychiatric conditions, areas where conventional therapeutics have encountered obstacles.
22/03/24 - Researchers at St Jude Children's Research Hospital used high throughput screening (HTS) to identify SJ3149, a molecular glue degrader. This small molecule demonstrated efficacy across a range of cancer types.
20/03/24 - Novo Nordisk and NVIDIA join forces to build an AI supercomputer which will be housed in Denmark's national centre for AI innovation.
11/03/24 - Artificial Intelligence (AI) has significantly transformed high throughput screening (HTS) in drug discovery, increasing efficiency, accuracy, and predictive capabilities in early drug development stages. This research highlights AI's integration into HTS processes, showcasing improved outcomes in hit identification, assay optimization, and target validation, thus accelerating and refining the search for new medications.
05/03/24 - Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.

Online Activities

26/06/24, 16:00 BST | 8:00 PT | Science Exchange

Controlled Release Formulations

Presented by Moderator: Apoorva Sarode, Principal Scientist (Technology), Genentech Panellists: Yogeshwar Bachhav, Director, AiCuris Anti-infective Cures AG; René Holm, Professor, University of Southern Denmark
02/09/24 | Science Exchange

Excipients & Their Role In Drug Stability

01/10/24 | Science Exchange

Discovery of Novel Therapeutic Modalities

01/11/24 | Science Exchange

AI/ML: The Future Of Formulation & Delivery

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

Oxford Global PLUS


Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery